NXTM Insider Trading Activity and SEC Form 4 Filings
NXTM insider trading summary
No open-market insider purchases or sales of NxStage Medical, Inc. (NXTM) have been reported on SEC Form 4 in the past 12 months.
Latest NXTM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 20, 2018 | Winifred L Swan | SVP and General Counsel | Sell | $86K (3,500 @ $24.48) |
| Jan 16, 2018 | Winifred L Swan | SVP and General Counsel | Sell | $87K (3,500 @ $24.88) |
| Dec 20, 2017 | Winifred L Swan | SVP and General Counsel | Sell | $89K (3,500 @ $25.35) |
| Nov 15, 2017 | Winifred L Swan | SVP and General Counsel | Sell | $90K (3,500 @ $25.73) |
| Oct 20, 2017 | Winifred L Swan | SVP and General Counsel | Sell | $96K (3,500 @ $27.50) |
| Oct 20, 2017 | Matthew W Towse | SVP and Chief Financial Office | Sell | $111K (4,030 @ $27.50) |
| Oct 4, 2017 | Joseph E Turk Jr | President | Sell | $28K (1,000 @ $27.56) |
| Sep 20, 2017 | Winifred L Swan | SVP and General Counsel | Sell | $95K (3,500 @ $27.27) |
| Sep 20, 2017 | Matthew W Towse | SVP and Chief Financial Office | Sell | $117K (4,300 @ $27.27) |
| Sep 5, 2017 | Joseph E Turk Jr | President | Sell | $28K (1,000 @ $27.95) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.